NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time.

Author(s): Vassilakopoulou M, Parisi F, Siddiqui S, England AM, Zarella ER, Anagnostou V, Kluger Y, Hicks DG, Rimm DL, Neumeister VM

Publication: Lab Invest, 2015, Vol. 95, Page 334-341

PubMed ID: 25418580 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of cold ischemia time on the antigenicity of 12 phosphoproteins in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissue.

Conclusion of Paper

Phospho-Tyrosine 4G10 and phospho-extracellular-signal-regulated kinases (Erk) 1/2 showed significantly decreased immunostaining with longer cold ischemia times. For phospho-protein kinase B (AKT), phospho-mammalian target of rapamycin (mTor), phospho-signal transducer and activator of transcription 3 (Stat3), phospho-stress activated protein kinase (SAPK), and phospho-Met, non-significant decreases in immunostaining were observed with increased cold ischemia time. Phospho-heat shock protein 27 (HSP27) immunostaining increased significantly while ribosomal protein phospho-S6 immunostaining showed a non-significant increase as cold ischemia time increased. Phospho-estrogen receptor (ER) and phospho-Janus kinase 2 (Jak2) immunostaining levels were not significantly affected by cold ischemia time.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of cold ischemia time on the antigenicity of 11 phosphoproteins in FFPE breast cancer tissue. A tissue microarray containing 93 breast cancer specimens (in duplicate) with a range of known cold ischemia times (25-415 min) was evaluated and quantitative immunofluorescence was performed using the Automated Quantitative Analysis (AQUA) method. Although initially included in the analysis, the authors report that statistical evaluation of phospho- human epidermal growth factor receptor 2 (Her2) staining was unable to be performed due to low numbers of Her2 positive cases and few specimens showing staining above the threshold to noise signal. 

    Summary of Findings:

    Phospho-Tyrosine 4G10 and phospho-Erk1/2 showed significantly decreased immunostaining with longer cold ischemia times. For phosphor-AKT, phospho-mTor, phospho-Stat3, phospho-SAPK, and phospho-Met, non-significant decreases in immunostaining were observed with increased cold ischemia time. Phospho-HSP27 immunostaining increased significantly while ribosomal protein phospho-S6 immunostaining showed a non-significant increase as cold ischemia time increased. Phospho-ER and phospho-Jak2 immunostaining levels were not significantly affected by cold ischemia time.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunohistochemistry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Cold ischemia time <30 min
    30-45 min
    45-60 min
    60-75 min
    75-90 min
    95-120 min
    >120 min
    Immunohistochemistry Specific Targeted peptide/protein Phospho-Her2
    Phospho-ER
    Phospho-Erk1/2
    Phospho-Akt
    Phospho-Stat3
    Phospho-S6 Ribosomal Protein
    Phospho-Jak2
    Phospho-Met
    Phospho-SAPK/JNK
    Phospho-mTOR
    4G10 Antiphosphotyrosine
    pHSP27

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...